@article{ART002952841},
author={Young-ro Kim},
title={A Case Study on Patients with Hematologic Malignancies Receiving Ortho-Cellular Nutrition Therapy (OCNT)},
journal={CELLMED},
year={2023},
volume={13},
number={5},
pages={20-20},
doi={10.5667/CellMed.spc.020}

TY - JOUR
AU - Young-ro Kim
TI - A Case Study on Patients with Hematologic Malignancies Receiving Ortho-Cellular Nutrition Therapy (OCNT)
JO - CELLMED
PY - 2023
VL - 13
IS - 5
PB - Cellmed Orthocellular Medicine and Pharmaceutical Association
SP - 20
EP - 20
AB - Objective: A case report on the improvement of patients with hematologic malignancies by Ortho-Cellular Nutrition Therapy (OCNT). Methods: A 69-year-old Korean female diagnosed with Stage 4 ACUTE LYMPHOBLASTIC Leukemia (ALL) had a very low platelet count of 8000/μl. Results: The platelet count improved to its normal level after Ortho-Cellular Nutrition Therapy (OCNT). Conclusion: Ortho-Cellular Nutrition Therapy (OCNT) is effective in relieving the symptoms of acute lymphoblastic leukemia patients with thrombocytopenia.
KW - Ortho-Cellular Nutrition Therapy (OCNT);ACUTE LYMPHOBLASTIC Leukemia (ALL);and Platelet
DO - 10.5667/CellMed.spc.020
ER -

Young-ro Kim. (2023). A Case Study on Patients with Hematologic Malignancies Receiving Ortho-Cellular Nutrition Therapy (OCNT). CELLMED, 13(5), 20-20.

Young-ro Kim. 2023, "A Case Study on Patients with Hematologic Malignancies Receiving Ortho-Cellular Nutrition Therapy (OCNT)", CELLMED, vol.13, no.5 pp.20-20. Available from: doi:10.5667/CellMed.spc.020

Young-ro Kim "A Case Study on Patients with Hematologic Malignancies Receiving Ortho-Cellular Nutrition Therapy (OCNT)" CELLMED 13.5 pp.20-20 (2023) : 20.

Young-ro Kim. A Case Study on Patients with Hematologic Malignancies Receiving Ortho-Cellular Nutrition Therapy (OCNT). 2023; 13(5), 20-20. Available from: doi:10.5667/CellMed.spc.020

Young-ro Kim. "A Case Study on Patients with Hematologic Malignancies Receiving Ortho-Cellular Nutrition Therapy (OCNT)" CELLMED 13, no.5 (2023) : 20-20.doi: 10.5667/CellMed.spc.020

Young-ro Kim. A Case Study on Patients with Hematologic Malignancies Receiving Ortho-Cellular Nutrition Therapy (OCNT). CELLMED, 13(5), 20-20. doi: 10.5667/CellMed.spc.020

Young-ro Kim. A Case Study on Patients with Hematologic Malignancies Receiving Ortho-Cellular Nutrition Therapy (OCNT). CELLMED. 2023; 13(5) 20-20. doi: 10.5667/CellMed.spc.020

Young-ro Kim. A Case Study on Patients with Hematologic Malignancies Receiving Ortho-Cellular Nutrition Therapy (OCNT). 2023; 13(5), 20-20. Available from: doi:10.5667/CellMed.spc.020

Young-ro Kim. "A Case Study on Patients with Hematologic Malignancies Receiving Ortho-Cellular Nutrition Therapy (OCNT)" CELLMED 13, no.5 (2023) : 20-20.doi: 10.5667/CellMed.spc.020